Ligand validation:7CP5

TGL: TRISTEAROYLGLYCEROL

TGL is a Ligand Of Interest in 7CP5 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7CP5_TGL_N_609	34%	44%	0.185	0.87	1.13	1.07	3	4	2	0	100%	1
7CP5_TGL_L_103	30%	53%	0.175	0.858	0.74	1.08	1	3	7	0	89%	0.8889
7CP5_TGL_D_202	28%	42%	0.162	0.833	1.17	1.13	3	5	7	0	90%	0.9048
7CP5_TGL_B_301	27%	35%	0.151	0.836	1.16	1.47	3	5	0	0	78%	0.7778
7CP5_TGL_N_611	14%	82%	0.185	0.773	0.36	0.44	-	-	2	0	76%	0.7619
7CP5_TGL_N_612	12%	32%	0.226	0.81	1.18	1.6	2	8	2	0	70%	0.6984
5B1A_TGL_B_301	58%	10%	0.119	0.898	1.71	2.82	8	21	2	0	100%	1
5ZCQ_TGL_A_608	51%	24%	0.146	0.899	1.36	1.87	5	11	1	0	100%	1
5ZCP_TGL_A_608	49%	20%	0.149	0.895	1.31	2.24	6	10	1	0	100%	1
5B3S_TGL_B_301	48%	38%	0.154	0.897	1.1	1.4	3	6	3	0	100%	1
6JUW_TGL_A_610	48%	38%	0.137	0.878	1.18	1.34	3	6	0	0	100%	1
7W3E_TGL_B_301	45%	32%	0.145	0.881	1.18	1.61	3	9	2	0	98%	0.9841

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.